PlainPatent
USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Solta Medical Ireland Limited

USPTO PatentsView assignee record - 12 granted patents across 6 technology areas, recorded in grant years 2022–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

RSS updates for this company
Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Solta ranks #23,428 of 49,997 tracked US assignees by granted-patent volume, with 12 patents across 6 technology areas.

#23,428
of 49,997 US assignees by volume
Top 29%
by Innovation Score (42.9/100)
9.0
avg claims per patent

USPTO PatentsView assignee plate

Corpus R23428 · Foreign Corporation #23,428 · 12 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-PAR · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH

  • GRANTS-MICRO 12 grants
  • MID-PACK #23,428/49,997
  • PHOTO-FINISH Smiths Heimann SAS
  • CPC-NARROW A61B · 6 areas
  • INNOV-PAR 42.9/100
  • CLAIMS-PAR 9.0 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • SPAN-YRS 2022–2025 · 4y
  • BOOK-RICH 9/10 fields

Nearest grant-volume peer: Smiths Heimann SAS (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Solta’s 42.9 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Solta

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Solta's Innovation Score is 42.9/100 (top 29% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Solta?

Each dot is one of Solta’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Solta’s own 9.0 claims/patent is at or below the 18.4 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Solta vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 11.911.91212.1 510152025 Granted patents (volume) Avg claims / patent Smiths Heimann SAS - 12, 18.42Smiths Heimann SASSoftware Motor Company - 12, 21.5Software MotorSoligenix, Inc. - 12, 10.08SoligenixSolsten, Inc. - 12, 17.58SolstenSomaLogic Operating Co., Inc. - 12, 19.42Somalogic Operati…South East Water Corporation - 12, 22.75South East WaterSouthern Innovation International Pty Ltd - 12, 19.5Southern Innovati…Spartan Motors, Inc. - 12, 17.67Spartan MotorsSolta Medical Ireland Limited - 12, 9Solta Medical Ire…
Solta vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Solta's grants concentrate

Solta Medical Ireland Limited is a focused PatentsView assignee: 6 CPC subclasses with 41.7% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2024 (4 grants) versus a trough of 1 in 2023. By volume, Solta sits between Smiths Heimann SAS and Spartan Motors, Inc..

Solta's three-year grant acceleration

Solta Medical Ireland Limited shows 8 grants in 2022–2024 against only 0 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Solta's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Solta holds 12 patents at rank #23,454, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Solta

By rank, the assignees closest to #23,454 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Solta's primary technology class.

Solta's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

43 Top 29% higher than 71% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

012345 2022202320242025 4
USPTO utility patent grants by year · 2022–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2022–2019 baseline. Full figures in the table below.

View data table
Solta Medical Ireland Limited patent grants by year, 2015–2025
Year Patents Granted Share of Period
2022 3 25.0%
2023 1 8.3%
2024 4 33.3%
2025partial year 4 33.3%

Which technologies does Solta Medical Ireland Limited patent most?

Top 6 of 6 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Solta Medical Ireland Limited's patent record in context - here's where to go next.

  • Solta Medical Ireland Limited's lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 41.7% of its portfolio - see every assignee active in that class. Explore A61B
  • Ranked #23,428 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Solta Medical Ireland Limited against Smiths Heimann SAS, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 42.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page
  • USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
  • Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
  • USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.